NCT02548286

Study to Compare the Safety and Pharmacokinetics of CKD-330 8/5mg With Coadministration of the Two Separate Drugs

A Randomized, Open-label, Single-dosing, Crossover Study to Compare the Safety and Pharmacokinetics of CKD-330(Fixed-dose Combination of Candesartan Cilexetil 8 mg and Amlodipine 5 mg) With Coadministration of the Two Separate Drugs in Healthy Male Volunteers(B)

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 53 (actual)
• Sponsor: Chong Kun Dang Pharmaceutical · Industry
• Sex: Male
• Age: 19 Years – 45 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to compare the safety and pharmacokinetics of CKD-330 (fixed-dose combination of Candesartan Cilexetil 8 mg and Amlodipine 5 mg) with coadministration of the two separate drugs in healthy male volunteers.

Conditions

• Hypertension

Interventions

Type	Name	Description
DRUG	Candesartan 8mg	PO, 1day or 22day
DRUG	Amlodipine 5mg	PO, 1day or 22day
DRUG	CKD-330 8/5mg	PO, 1day or 22day

Timeline

• Start date: 2015-08-01
• Primary completion: 2015-08-01
• Completion: 2015-09-01
• First posted: 2015-09-14
• Last updated: 2015-12-07

Locations

1 site across 1 country: South Korea